{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:08:46Z","timestamp":1790161726514,"version":"4.1.0"},"reference-count":96,"publisher":"SAGE Publications","issue":"13","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) is characterized by chronic systemic inflammation, frequent corticosteroid exposure, and heightened cardiometabolic vulnerability. Metabolic syndrome (MetS) has become a clinically significant comorbidity among individuals with SLE. We performed an updated systematic review and meta-analysis to better understand the prevalence and identify the factors associated with the occurrence of MetS in SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Scopus, and Web of Science were systematically searched through January 4, 2026 to identify observational studies reporting the prevalence of MetS among individuals with SLE. Random-effects meta-analytic models were applied to calculate pooled prevalence estimates and evaluate the associations with potential risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall pooled prevalence of MetS in patients with SLE was estimated at 0.27 (95% CI: 0.24\u20130.30). Sex-stratified analyses showed a prevalence of 0.36 (95% CI: 0.25\u20130.47) in male patients and 0.27 (95% CI: 0.23\u20130.30) in female patients. Across continents, the highest prevalence was observed in Africa (0.36, 95% CI: 0.30\u20130.41), followed by South America (0.32, 95% CI: 0.24\u20130.40), Asia (0.27, 95% CI: 0.22\u20130.32), Europe (0.23, 95% CI: 0.18\u20130.28), and North America (0.21, 95% CI: 0.14\u20130.30). Regarding medication use, hydroxychloroquine was associated with a significantly reduced risk of MetS (OR = 0.66, 95% CI: 0.52\u20130.83; P &lt; 0.01), whereas cyclophosphamide (OR = 1.39, 95% CI: 1.06\u20131.81; P = 0.02), azathioprine (OR = 1.25, 95% CI: 1.00\u20131.55; P = 0.04), and mycophenolate mofetil (OR = 1.13, 95% CI: 1.03\u20131.23; P = 0.01) were each associated with a significant increased risk of MetS. No significant associations were found for steroids (OR = 1.34, 95% CI: 0.97\u20131.83; P = 0.07), methotrexate (OR = 1.07, 95% CI: 0.78\u20131.47; P = 0.84), or cyclosporine use (OR = 1.19, 95% CI: 0.64\u20132.21; P = 0.33). The analysis also identified several risk factors for MetS in SLE patients. Patients with MetS were older (Hedges\u2019 g = 0.47; P &lt; 0.01), had higher BMI (Hedges\u2019 g = 0.88; P &lt; 0.01), and higher total cholesterol (Hedges\u2019 g = 0.39; P &lt; 0.01) and LDL levels (Hedges\u2019 g = 0.41; P &lt; 0.01) than those without MetS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MetS is prevalent among individuals with SLE and is influenced by demographic, clinical, and treatment-related factors. These findings highlight the need for targeted monitoring and management strategies to reduce the cardiometabolic risk in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033261477274","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:29:31Z","timestamp":1788942571000},"page":"1354-1381","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"35","author":[{"given":"Sandeep","family":"Samethadka Nayak","sequence":"first","affiliation":[{"name":"Yale New Haven Health Bridgeport Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Ghodous","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narsimha Rao","family":"Keetha","sequence":"additional","affiliation":[{"name":"Ohio Kidney and Hypertension Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Gurram","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine Cleveland Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Letafatkar","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Ahlawat","sequence":"additional","affiliation":[{"name":"Yale New Haven Health Bridgeport Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Habibi","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa Ramanujan","family":"Boora","sequence":"additional","affiliation":[{"name":"Pennstate Health Holy Spirit Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Hormozgan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivaramakrishna","family":"Cheetirala","sequence":"additional","affiliation":[{"name":"Advocate Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amouzadeh-Lichahi","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarpong","family":"Boateng","sequence":"additional","affiliation":[{"name":"Yale New Haven Health Bridgeport Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Jafari","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Ponnala","sequence":"additional","affiliation":[{"name":"Pennstate Health Holy Spirit Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asal","family":"Khorami","sequence":"additional","affiliation":[{"name":"Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Joshi","sequence":"additional","affiliation":[{"name":"Yale New Haven Health Bridgeport Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Saberi","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmirAli","family":"Moodi Ghalibaf","sequence":"additional","affiliation":[{"name":"Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Arumairaj","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine Department of Internal Medicine Woodhull Medical Center, NYU Langone760 Broadway Brooklyn, NY 11206, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4985-2899","authenticated-orcid":false,"given":"Ehsan","family":"Amini-Salehi","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Sharma","sequence":"additional","affiliation":[{"name":"Yale New Haven Health Bridgeport Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02168-0"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa382"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1620601"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-021-00965-2"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13153"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.346312.120"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1661603"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317751047"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/21501319241309168"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S486792"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00929-5"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092154"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974826"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac067"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3602-0"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3316-z"},{"issue":"3","key":"e_1_3_6_20_2","first-page":"195","article-title":"Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits","volume":"7","author":"Hatef-Fard MR","year":"2016","unstructured":"Hatef-Fard MR, Khodabandeh M, Sahebari M, et al. Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits. Caspian J Intern Med 2016; 7(3): 195\u2013200.","journal-title":"Caspian J Intern Med"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_6_22_2","first-page":"217","volume-title":"Systematic reviews of etiology and risk","author":"Moola S","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, et al. Systematic reviews of etiology and risk. JBI manual for evidence synthesis, 2020, vol 1, pp. 217\u2013269."},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4269-x"},{"issue":"1","key":"e_1_3_6_24_2","first-page":"20","article-title":"Frequency and clinical implications of metabolic syndrome in different rheumatic diseases: relationship with disease activity and severity","volume":"17","author":"Al-Adle SS","year":"2025","unstructured":"Al-Adle SS, El-Husseiny PN, Eesa NN, et al. Frequency and clinical implications of metabolic syndrome in different rheumatic diseases: relationship with disease activity and severity. Journal of Turkish Society For Rheumatology 2025; 17(1): 20\u201329. https:\/\/doi.org\/10.4274\/raed.galenos.2025.27247","journal-title":"Journal of Turkish Society For Rheumatology"},{"issue":"5","key":"e_1_3_6_25_2","first-page":"73","article-title":"Frequency of metabolic syndrome (METS) in patients with systemic lupus erythematosis (SLE)","volume":"32","author":"Ali A","year":"2021","unstructured":"Ali A, Andleeb S, Uthman M. Frequency of metabolic syndrome (METS) in patients with systemic lupus erythematosis (SLE). Medical Forum Monthly 2021; 32(5): 73\u201376.","journal-title":"Medical Forum Monthly"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000436"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110237"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2014.07.006"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309105876"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injr.2015.07.005"},{"issue":"1","key":"e_1_3_6_31_2","first-page":"32","article-title":"Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus","volume":"26","author":"Bultink IE","year":"2008","unstructured":"Bultink IE, Turkstra F, Diamant M, et al. Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. Clin Exp Rheumatol 2008; 26(1): 32\u201338.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603138"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab090"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054973"},{"issue":"3","key":"e_1_3_6_35_2","first-page":"299","article-title":"Association of the disease duration and administered therapy with metabolic syndrome in patients with systemic lupus erythematosus","volume":"40","author":"Cvetkovic JM","year":"2023","unstructured":"Cvetkovic JM, Stojanovic SK, Tasic IS, et al. Association of the disease duration and administered therapy with metabolic syndrome in patients with systemic lupus erythematosus. Acta Fac Med Naissensis 2023; 40(3): 299\u2013306. https:\/\/doi.org\/10.5937\/afmnai40-40813","journal-title":"Acta Fac Med Naissensis"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603140"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318782424"},{"issue":"1","key":"e_1_3_6_38_2","first-page":"50","article-title":"Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus","volume":"33","author":"El Magadmi M","year":"2006","unstructured":"El Magadmi M, Ahmad Y, Turkie W, et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 2006; 33(1): 50\u201356.","journal-title":"J Rheumatol"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2018.06.001"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211061481"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130817"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3970-5"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13715"},{"issue":"2","key":"e_1_3_6_44_2","first-page":"172","article-title":"Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness","volume":"72","author":"Gheita TA","year":"2013","unstructured":"Gheita TA, Raafat HA, Sayed S, et al. Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. Rheumatol 2013; 72(2): 172\u2013177. https:\/\/doi.org\/10.1007\/s00393-012-1058-9","journal-title":"Rheumatol"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05731-6"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090011"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-018-0447-0"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-025-00464-5"},{"issue":"6","key":"e_1_3_6_49_2","first-page":"1220","article-title":"Metabolic syndrome in systemic lupus erythematosus was closely related to body mass index, blood pressure, blood sugar, blood lipids, and arthritis","volume":"36","author":"Jin LR","year":"2020","unstructured":"Jin LR, Tao MJ, Zhou J, et al. Metabolic syndrome in systemic lupus erythematosus was closely related to body mass index, blood pressure, blood sugar, blood lipids, and arthritis. Pakistan J Med Sci 2020; 36(6): 1220\u20131227. https:\/\/doi.org\/10.12669\/pjms.36.6.2093","journal-title":"Pakistan J Med Sci"},{"issue":"07","key":"e_1_3_6_50_2","first-page":"960","article-title":"Metabolic syndrome;: frequency of metabolic syndrome in patients of systemic lupus erythematosus","volume":"24","author":"Khalid M","year":"2017","unstructured":"Khalid M, Anwar T, ur Rehman N, et al. Metabolic syndrome;: frequency of metabolic syndrome in patients of systemic lupus erythematosus. Prof Med J 2017; 24(07): 960\u2013965. https:\/\/doi.org\/10.17957\/tpmj\/17.3846","journal-title":"Prof Med J"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X221113400"},{"key":"e_1_3_6_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-017-1689-z"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00213"},{"key":"e_1_3_6_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313478301"},{"key":"e_1_3_6_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311411348"},{"key":"e_1_3_6_56_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-024-00453-z"},{"key":"e_1_3_6_57_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187645"},{"key":"e_1_3_6_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13276"},{"key":"e_1_3_6_59_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009740903046668"},{"issue":"3","key":"e_1_3_6_60_2","first-page":"389","article-title":"Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis","volume":"36","author":"Mok CC","year":"2018","unstructured":"Mok CC, Tse SM, Chan KL, et al. Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis. Clin Exp Rheumatol 2018; 36(3): 389\u2013395.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318790676"},{"key":"e_1_3_6_62_2","doi-asserted-by":"publisher","DOI":"10.21608\/smj.2025.421485.1613"},{"key":"e_1_3_6_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22593"},{"key":"e_1_3_6_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307086645"},{"key":"e_1_3_6_65_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.3721"},{"key":"e_1_3_6_66_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02453-5"},{"key":"e_1_3_6_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312462756"},{"key":"e_1_3_6_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311416695"},{"key":"e_1_3_6_69_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203933"},{"key":"e_1_3_6_70_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313517405"},{"key":"e_1_3_6_71_2","doi-asserted-by":"publisher","DOI":"10.5937\/jomb0-45732"},{"key":"e_1_3_6_72_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309355301"},{"issue":"4","key":"e_1_3_6_73_2","first-page":"483","article-title":"Grp Lupus Virgen de las N. Effects of low or medium-dose of prednisone on insulin resistance in patients with systemic lupus erythematosus","volume":"28","author":"Sabio JM","year":"2010","unstructured":"Sabio JM, Vargas-Hitos JA, Navarrete N, et al. Grp Lupus Virgen de las N. Effects of low or medium-dose of prednisone on insulin resistance in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2010; 28(4): 483\u2013489.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_74_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308093554"},{"key":"e_1_3_6_75_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317723716"},{"issue":"3","key":"e_1_3_6_76_2","first-page":"325","article-title":"Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients","volume":"35","author":"Santos MJ","year":"2010","unstructured":"Santos MJ, Vinagre F, da Silva JC, et al. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients. Acta Reumatologica Portuguesa 2010; 35(3): 325\u2013332.","journal-title":"Acta Reumatologica Portuguesa"},{"key":"e_1_3_6_77_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309359781"},{"key":"e_1_3_6_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu434"},{"key":"e_1_3_6_79_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080503"},{"key":"e_1_3_6_80_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2013.803150"},{"key":"e_1_3_6_81_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316668040"},{"key":"e_1_3_6_82_2","unstructured":"Wang SL Li W Li TF Liang X Yan YL Liu SY. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus. Am J Transl Res. 2022 May 15;14(5):3247-3260."},{"key":"e_1_3_6_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000343"},{"key":"e_1_3_6_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31816b2faa"},{"key":"e_1_3_6_85_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071988"},{"key":"e_1_3_6_86_2","doi-asserted-by":"publisher","DOI":"10.4103\/jrms.JRMS_858_18"},{"key":"e_1_3_6_87_2","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13010012"},{"key":"e_1_3_6_88_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058333"},{"key":"e_1_3_6_89_2","doi-asserted-by":"publisher","DOI":"10.34172\/jrhs.2024.139"},{"key":"e_1_3_6_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16004"},{"key":"e_1_3_6_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07369-9"},{"key":"e_1_3_6_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23237"},{"key":"e_1_3_6_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.08.002"},{"key":"e_1_3_6_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3502"},{"key":"e_1_3_6_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00922-y"},{"key":"e_1_3_6_96_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1077166"},{"issue":"2","key":"e_1_3_6_97_2","first-page":"62","article-title":"Study of the metabolic syndrome severity index as a predictive factor of a major cardiovascular event in premenopausal women with systemic lupus erythematosus","volume":"163","author":"Garc\u00eda-Villegas EA","year":"2024","unstructured":"Garc\u00eda-Villegas EA, Vargas-de-Le\u00f3n C, Villa-Romero AR, et al. Study of the metabolic syndrome severity index as a predictive factor of a major cardiovascular event in premenopausal women with systemic lupus erythematosus. Med Cl\u00ednica 2024; 163(2): 62\u201369. https:\/\/doi.org\/10.1016\/j.medcle.2024.01.026","journal-title":"Med Cl\u00ednica"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261477274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033261477274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261477274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:16:33Z","timestamp":1790158593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033261477274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":96,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/09612033261477274"],"URL":"https:\/\/doi.org\/10.1177\/09612033261477274","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}